Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
about
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation.Quantification of mixed chimerism allows early therapeutic interventions.Hematopoietic stem cell transplantation for MDS.Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesSustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report.CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseCellular therapy following allogeneic stem-cell transplantation.Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.Donor lymphocyte infusions: the long and winding road: how should it be traveled?Transplantation for myelodysplastic syndromes 2013.Recent advances in quantitative chimerism analysis.Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status.Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.Lineage-specific chimerism analysis in nucleated cells, T cells and natural killer cells after myeloablative allogeneic hematopoietic stem cell transplantation.A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantationCombination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate.Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia.Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations.
P2860
Q33405278-3C49AD8A-2CA0-4C24-AD76-F1FF21C364CCQ33418127-1448BFD4-C46D-424B-B0A6-C551387108EBQ33767314-F769A032-912F-4127-971A-3408CAF636B3Q36266642-24BF03BB-8FE5-40BC-A491-55973B38071AQ36581381-FB49AF2C-D1A0-4181-9130-6A9A4F3BDB91Q36608689-8706FFE9-EAFF-42FA-ABBB-3D887D26949DQ36612643-3AC8C7BB-6C45-45ED-9ECA-2812731863AAQ36712059-16FC56FA-B78A-4803-BA33-2170139779A7Q37246638-D04F08C9-FBE5-4275-A764-34D2AD76FE10Q37600407-C80519D9-87CF-4554-B4C4-9DB5A76C7955Q37628681-16691A6D-12AF-46A6-BD23-03F673D6E14BQ37676299-D9AFC2C9-AAF1-447E-B5F9-56905789BD17Q37955235-3399844F-F2C4-48E3-8D56-A4C74D79A33FQ37964938-C22633E2-A4D1-45A1-8CA3-F477331B105AQ39092515-4AAA68E3-ADC1-49F7-B3C5-C41B1C017E08Q39764454-9E168138-F0EC-40BF-ADF8-89E2328C37CAQ41273685-F98E7A2E-7D23-439C-8921-D8D945BC69ABQ41900749-EA2B66A0-ACC5-4EC4-AA97-01F39D1DC4D8Q42025658-B6672F9F-A866-4085-9A90-44FA18F2A17CQ43451303-93716525-140C-4D01-BC42-E37F5FBC376FQ52774309-A8E583B5-C4D5-4EDC-A238-39A50F57513E
P2860
Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Results of donor lymphocyte in ...... opoietic cell transplantation.
@en
Results of donor lymphocyte in ...... opoietic cell transplantation.
@nl
type
label
Results of donor lymphocyte in ...... opoietic cell transplantation.
@en
Results of donor lymphocyte in ...... opoietic cell transplantation.
@nl
prefLabel
Results of donor lymphocyte in ...... opoietic cell transplantation.
@en
Results of donor lymphocyte in ...... opoietic cell transplantation.
@nl
P2093
P2860
P356
P1476
Results of donor lymphocyte in ...... opoietic cell transplantation.
@en
P2093
B Sandmaier
M E D Flowers
P J Martin
P V Campregher
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705840
P407
P577
2007-09-10T00:00:00Z
P5875
P6179
1033981374